“…The term refers to a collection of autosomal-recessive genetic disorders characterized by the hemoglobin S (HbS) variant of the b-globin gene that is resistant to malaria development and in which more than 50% the hemoglobin-b gene is replaced with HbS (El-Hazmi, Al-Hamzi, & Warsy, 2011;Saraf et al, 2014). SCD affects 1 in 500 African Americans and more than 30 million people worldwide, with predominance in populations of the sub-Sahara, India, and the Middle East (Inati et al, 2007;Khoriaty et al, 2014;McGann, 2014). There are different variants of the b-globin gene in SCD, including but not limited to sickle cell anemia, sickle-hemoglobin C disease, sickle beta-plus thalassemia, and sickle beta-zero thalassemia, with prevalence of certain variants types in particular ethnic groups (El-Hazmi et al, 2011;Saraf et al, 2014).…”